Purpose Ppars belong to nuclear hormone receptor superfamily, and are primarily involved in lipid metabolism. Recent reports suggest that they may also regulate the expression of drug transporters in the liver and intestine. Recently, we have demonstrated that PPARα can regulate the expression and function of the drug efflux transporter, BCRP, in cerebral microvascular endothelial cells (hCMEC/D3), a widely used in vitro cell line model of human BBB. The purpose of this study was to investigate, ex vivo and in vivo, the role of Pparα in Bcrp regulation at the BBB.
Results
For in vivo experiments, our immunoblot analysis showed: 1) significant Bcrp protein upregulation in brain capillary lysates of CD-1 mice treated with clofibrate (in vehicle, ~141% or without vehicle, ~160%) compared to no treatment control (100%) and vehicle control; 2) significant Bcrp protein upregulation in brain capillary lysates of C57BL/6 mice treated with clofibrate (in vehicle, ~134%) compared to vehicle treatment (corn oil, 100%) 3) no difference in Bcrp protein expression between brain capillaries isolated from clofibrate treated versus vehicle treated PPARα KO mice. For ex vivo experiments, our qPCR analysis demonstrated significant upregulation of Abcg2 mRNA levels in isolated brain capillaries obtained from CD-1 mice brains, treated ex vivo with clofibrate (~174%) compared to vehicle treated controls (100%). Conclusion Together these data suggest that Bcrp can be induced by PPARα selective ligand at the BBB. Since Bcrp is recognized to play major role in brain drug permeability, these findings may provide new strategies for limiting brain permeability of neurotoxins. (Supported by CIHR)
